Today we reported our Q1 2023 financial results. Read our press release to learn more about our recent clinical and corporate highlights: bit.ly/3O86bSx

Today we announced a new #CRADA with the @NIEHS to use #ThinFilmFreezing for the prevention & treatment of respiratory diseases. We look forward to exploring our technology’s potential under this agreement. Learn more here: bit.ly/3LCjdEC

We’ve been awarded additional funding from @LeidosInc to advance next-gen countermeasures for #military & #healthcare personnel with @DARPA We look forward to continuing to explore the potential of #ThinFilmFreezing for #biodefense. More here: bit.ly/3LdP9PG

#ThinFilmFreezing inventor and TFF special advisor Dr. Bill Williams has made the @medicine_maker 2023 Power List! We are proud to work with such a talented industry leader whose innovative research helps us make a difference for patients. More here: bit.ly/3NdMpob

Read in @WRALTechWire about how our North Carolina-based team, including world renowned aerosol biologist Dr. Anthony Hickey & industry veteran Dr. Dale Christensen, are advancing #ThinFilmFreezing technology to improve #drugdelivery. Learn more here: bit.ly/3KT28WV

Tomorrow our Chief Scientific Officer, Tony Hickey, Ph.D., is speaking at @AstraZenecaUS’ “Inhaled Biologics: Challenges, Opportunities, and Future Directions” event in Gaithersburg, Maryland. Learn more about the event and register here: bit.ly/3FEkdGl

Our Manager of Process Engineering, Kayla Hannon, will participate in a panel with @BioProcessOL Live on Tuesday, April 18 to discuss insights on surge #manufacturing for #biopharma resilience. Register to watch and learn more here: bit.ly/407vV48

We are exploring the broad applications of #ThinFilmFreezing through our two internal clinical-stage programs. Learn more about our inhaled #voriconazole and #tacrolimus clinical trials here: bit.ly/3KwavsF

Last month we held a webcast to discuss TFF’s corporate objectives for 2023. We plan to put a focus on our internal pipeline of inhaled #voriconazole and inhaled #tacrolimus while maintaining our strategic partnerships. Access the recording here: bit.ly/3S2Oxze

Check out this @BioProcessIntl article where Dr. Robert O. Williams, the inventor of #ThinFilmFreezing discusses its benefits and the progress of his research at @UTAustin in collaboration with TFF Pharmaceuticals. Read the article here: bit.ly/3JxR3db

#ICYMI Our CEO Harlan Weisman, M.D. & CMO Zamaneh Mikhak, M.D. spoke about the potential of our TFF VORI & TFF TAC programs. We look forward to continuing to advance treatments using #ThinFilmFreezing technology for patients in need. Listen to learn more: bit.ly/3S2Oxze

Our CEO Dr. Harlan Weisman will participate in a fireside chat at the 35th Annual Roth Conference on Monday, March 13 at 10:30 a.m. PT. Click here to register and learn more: bit.ly/3F2fmyp $TFFP

We’re excited to announce that Dr. Bill Williams and his team at @UTexasPharmacy’s publication on the use of Thin Film Freezing to improve delivery of biologics was selected as a 2023 featured article in the KONA Powder and Particle Journal. Take a look: bit.ly/3L9c5Bn

Yesterday we reported our fourth quarter 2022 and full year 2022 financial results. Learn more about the progress of our programs and corporate goals for 2023 here: bit.ly/3Zyz3WL $TFFP

.@PHLBizJournal featured highlights from our recent business update call with new CEO Harlan Weisman, M.D. We look forward to further progressing our internal pipeline and developing high-value products using #ThinFilmFreezing technology. Read more here: bit.ly/3SBu3xW

What makes #ThinFilmFreezing different from other competing technologies? Our technology creates uniform particles that are suitable for dry powder inhalers, while other methods do not. Learn more about our technology here: bit.ly/3vTZE3h

Tune in at 4:30 p.m. ET today to hear from our newly appointed permanent CEO, Harlan Weisman, M.D. and newly appointed CMO, Zamaneh Mikhak, M.D. discuss TFF’s corporate strategy and objectives for 2023. Register to attend here: bit.ly/3S2Oxze

Tomorrow is the #InternationalDayofWomenandGirlsinScience! Hear from our new CMO, Dr. Zamaneh Mikhak, about her reflections as a #WomaninSTEM and learn how you can get involved here: bit.ly/3jaYOfW

Meet the Chairman of our Board of Directors, Aaron Fletcher, Ph.D. Dr. Fletcher has worked as an independent consultant in the industry for over 10 years & has a strong understanding of commercial viability in the marketplace. Learn more about him here: bit.ly/3XjPIfe

We are pleased to announce that Harlan Weisman, M.D. has been appointed as TFF’s permanent chief executive officer. We will host an investor call on Thursday, February 16 at 4:30 p.m. ET. Register for the call here: bit.ly/3IbdFRk